Collaborative and Licensing Opportunity Presentations

Home » Collaborative and Licensing Opportunity Presentations

The Collaborative and Licensing Opportunity Presentations are a great opportunity for TTOs, universities, research institutes and companies to showcase their early-stage technologies in front of potential partners in the Life Sciences field, in order to entail a collaborative project and/or a licensing deal.
The selected candidates will be offered to present and promote their assets in front of the BioFIT participants.
The winner will be recognised as the most promising early-stage technology in Europe in Life Sciences.

How does it work?

Before September 17th, 2026

APPLY

⚠️ To apply to the Collaborative and Licensing Opportunity Presentations you must be registered to BioFIT.⚠️

To apply, the candidate must:

Have an early-stage asset to entail a collaborative project and/or an opportunity to out-license
Be registered to BioFIT 2026
Fill out the online application form and submit it before September 17^th, 2026

Before September 17th, 2026

Before the event

BE SELECTED

All applications will be reviewed by a jury (composed of high level representatives and international experts from public and private institutions, life sciences industries, and investors) who will select the most promising early-stage assets.
The selected projects will have the opportunity to be presented during BioFIT.
The selected candidates will have the possibility to display a poster within the exhibition area during BioFIT.

Before the event

During BioFIT

PITCH & BE AWARDED

The pitchers will have a 5 min timeslot during BioFIT to present and to highlight the most innovative aspects of their early-stage assets, in front of a jury of experts and potential partners.
The pitchers will receive valuable feedback and advice from the panel of experts.
The most innovative asset will be selected by the jury of experts and by the audience.
The winner will be recognised during the 2^nd day of BioFIT as the most promising early-stage technology in Europe in Life Sciences.

During BioFIT